Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib

Table 6

Treatment response and prognosis for different patient scores stratified according to independent prognostic factors (pre-PLR level and post-NLR variation).

Treatment response and prognosis	Score			value
	0	1	2
DCR	87.5%	73.3%	38.5%	0.001
ORR	12.5%	3.5%	7.7%	0.175
mPFS (months)	5.5	3.5	1.5	0.001
mOS (months)	12.2	7.6	3	0.001

0: patients negative for both risk factors (pre-PLR level and post-NLR variation). 1: patients with 1 of the above mentioned prognostic factors. 2: patients with both prognostic factors. analyzed with chi-square test. analyzed with Fisher.